Logo 155 Pill - white capsule/oblong, 17mm
Pill with imprint Logo 155 is White, Capsule/Oblong and has been identified as Diltiazem Hydrochloride Extended-Release 240 mg. It is supplied by Slate Run Pharmaceuticals, LLC.
Diltiazem is used in the treatment of Atrial Fibrillation; Atrial Flutter; Angina Pectoris Prophylaxis; Heart Failure; High Blood Pressure and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 240 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 155
Diltiazem Hydrochloride Extended-Release
- Imprint
- Logo 155
- Strength
- 240 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Slate Run Pharmaceuticals, LLC
- Manufacturer
- Yichang Humanwell Oral Solid Dosage Plant
- National Drug Code (NDC)
- 70436-0197
Related images for "Logo 155"
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (186)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
- Diltiazem drug information
- Diltiazem (Intravenous) (Advanced Reading)
- Diltiazem Long-Acting Capsules
- Diltiazem Long-Acting Tablets
- Diltiazem 12-Hour Sustained-Release Capsules
Other brands
Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +7 more
Professional resources
- DilTIAZem monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
